The CD-PRO is a self-administered instrument developed in accordance with FDA Guidelines for Content Validity and Instrument Performance. It is intended for use in clinical trials evaluating treatment efficacy in adult patients (≥18 years of age) with moderate to severe Crohn’s disease (CD) treated in an outpatient setting.
The CD-PRO is conceptually designed as a collection of separate and distinct modules that assess the signs, symptoms, and impacts of CD:
- Signs and Symptoms
- Systemic Symptoms
- Coping Strategies
- Daily Life Impact
- Emotional Impact
Continue scrolling to find out more about: